Loading
Latest filing published 23 Sept 2026 for NeuPath Health Inc., €4,437. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 23 September 2026, Stephen Lemieux disclosed an open-market purchase of €4,437 in NeuPath Health Inc. No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration